Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Biogen's diroximel fumarate impresses at Phase 3 in relapsing multiple sclerosis; Pfizer supressed research suggesting arthritis drug Enbrel reduced...
Patient centricity, derived from the NHS-driven thinking “no decision about me, without me,” has been adopted by pharma to understand their patients...
Janssen has lifted the curtain on Phase 3 study findings for Darzalex  plus bortezomib, thalidomide and dexamethasone (VTd) before and after...
Phase 3 data from ASCO 2019 has shown Janssen’s leukaemia drug Imbruvica (ibrutinib) had significant benefits over ofatumumab.
Amgen has unveiled the first clinical data for its investigational KRAS inhibitor AMG 510, the first such therapy to reach clinical stage,...
The European Commission has granted a conditional marketing authorisation to bluebird bio’s gene therapy Zynteglo.
Walmart has joined the MediLedger network – a network of pharma firms who use a permissioned blockchain to manage the distribution of medical...
FDA approves new tests for chlamydia and gonorrhoea; Drugmakers colluded to drive up price of anti-nausea drug by 700%; Pharma firms paid Italian...
Pfizer has unveiled new Phase 3 data on the effectiveness of Lyrica (pregabalin) in the adjunctive treatment of primary generalised tonic-clonic (...
Newron Pharmaceuticals has halted a clinical trial of its schizophrenia drug evenamide after the FDA raised concerns about reports of CNS events in...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches